This message was sent to ##Email##
|
|
|
|
|
CNN
Coronavirus task force member Dr. Anthony Fauci issued a stark warning on June 30 to lawmakers on Capitol Hill, telling them he wouldn't be surprised if the US sees new cases of coronavirus rising to a level of 100,000 a day.
READ MORE
STAT News
An experimental new HIV treatment could, with just one dose, reduce the amount of virus in an infected person for up to six months. But experts aren’t convinced the advance will significantly change how we treat HIV anytime soon.
READ MORE
ScienceDaily LLC
An international research team led by Dr. Tali Ilovitsh of the Biomedical Engineering Department at Tel Aviv University developed a noninvasive technology platform for gene delivery into breast cancer cells. The technique combines ultrasound with tumor-targeted microbubbles.
READ MORE
 |
|
The miniiSED® is the newest addition to the iSED® family of ESR analyzers from ALCOR Scientific. The miniiSED®is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The miniiSED® is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
|
|
Medical Xpress
Melbourne researchers have developed a fast, new test for infections and infectious diseases that could transform Australia's ability to provide targeted clinical care and respond to pandemics and biosecurity threats.
READ MORE
|
Promoted by
|
|
|
|
 |
USA Today
A survey published by the Centers for Disease Control and Prevention found that 54% of people infected with coronavirus were unable to pinpoint who may have infected them.
Experts said the survey results underscore an important point: Community and asymptomatic spread is alive and well, which makes contact tracing especially difficult during the pandemic.
READ MORE
 |
|
Uncompromising performance in the storage of your valuable pharmaceuticals and vaccines, especially following frequent door openings, high ambient temperatures, power outages and brown-outs. Natural refrigerants, variable speed inverter compressors and integrated electronics combine to help this pharmacy refrigerator achieve facility sustainability objectives by minimizing environmental impact and employing energy-saving performance. Learn More
|
|
News-Medical.Net
Lung cancer is the second most common cancer in both men and women in the United States. It is also the leading cause of cancer death among both sexes, making up nearly 25% of all cancer deaths nationwide. This is why screening for lung cancer, especially among high risk groups like lifetime smokers, is so important.
READ MORE
|
|
Radiology Business
Breast cancer detected within one year after previous negative mammography studies appear to be more destructive in nature and it may not be attributed solely to the delayed diagnosis.
Rather, such “interval breast cancers,” as they’re commonly called, may have a uniquely aggressive biology that could require additional actions from radiologists, experts wrote June 30 in JAMA Network Open.
READ MORE
POZ
Among men who have sex with men, lung function impairment is more common in those living with HIV.
Researchers analyzed data on 1,067 men from the Multicenter AIDS Cohort Study, which is an ongoing study that enrolls MSM, with and without HIV, at four sites in the United States.
READ MORE
Advertisement
American Medical Technologists
 Enhance your credentials to work in the rapidly expanding field of molecular diagnostics
|
Technology Networks
Drugs that can ‘reprogram’ immune cells from protecting cancer to attacking it could be an effective new treatment for some men with advanced prostate cancer, a new study shows.
Researchers found that immune cells called macrophages, already drawn into prostate cancer tumours to help promote growth, can be targeted and rewired to attack the disease.
READ MORE
|
|
Five Levels of recovery with LGC Maine Standards’ family of liquid-ready, VALIDATE® Hemostasis products: D-Dimer, Fibrinogen, Heparin Anti-Xa. Meeting calibration verification regulatory requirements for calibrated test methods has never been easier.
|
|
|
|
|
|
Introducing the Yumizen C1200-AL (autoloader) chemistry analyzer from HORIBA Medical for laboratories that want big lab automation in a small footprint. With a throughput of 1200 tests/hour, dedicated STAT port and a large test menu, the Yumizen C1200-AL delivers accuracy, efficiencies and optimal workflow capabilities laboratories need for everyday use.
Learn more
|
|
|
|
|
Infectious Disease Advisor
According to an investigation published in the CDC Morbidity & Mortality Weekly Report, a multistate mumps outbreak resulted from extensive social contact with an asymptomatic, fully vaccinated index patient at a wedding, resulting in a total of 62 cases.
READ MORE
CNBC
Some countries with rapidly spreading coronavirus outbreaks might have to reinstate lockdowns and other restrictions to curb the spread of the virus, a top World Health Organization official said July 1.
Countries like Spain and Italy successfully drove back severe outbreaks with a comprehensive public health strategy that mobilized the public, said WHO Director-General Tedros Adhanom Ghebreyesus.
READ MORE
|
|
The National Institutes of Health
The National Institutes of Health has announced the provision of $75 million in funding over five years for the Electronic Medical Records and Genomics Genomic Risk Assessment and Management Network, which establish protocols and methodologies for improved genomic risk assessments for diverse populations and to integrate their use in clinical care.
READ MORE
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests.
Learn more
|
|
|
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, contact Andy Keith at 972-402-7707.
MORE
|
|
|
|
Forbes
An at-home treatment option is now possible for some breast cancer patients.
This is especially important in helping to protect this population from COVID-19 exposure.
The FDA has approved Phesgo, which is a combination of pertuzumab, trastuzumab and hyaluronidase-zzxf, for patients with early HER2-positive breast cancer or those where the cancer has spread to other parts of the body.
READ MORE
Infectious Disease Advisor
Bezlotoxumab, a human monoclonal antibody against Clostridioides difficile toxin B, was found to prevent recurrence of infection as well as C difficile-associated rehospitalizations, according to the results of an analysis recently published in the European Journal of Clinical Microbiology & Infectious Diseases.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
